REAL-TIME GLOBAL RESEARCH
Weekly Neurology Script Tracker: ACAD, AXSM, NBIX
Research evidence excerpt
Not for redistribution without written consent of Morgan Stanley
M
Update
August 14, 2026 12:33 PM GMT
Morgan Stanley & Co. LLC
Biotechnology | North America
Sean Laaman, Ph.D.
Equity Analyst
Weekly Neurology Script
Tracker: ACAD, AXSM, NBIX
Katherine Sun
Research Associate
Michael H Riad, Ph.D.
Research Associate
We highlight trends in IQVIA prescription data for select US
neurology products.
For the week ending Aug 07, total scripts for the US antipsychotic market grew
+2.6% Y/Y. Rolling 4-week total script (TRx) was +2.1% Y/Y and rolling 12-week TRx
was +2.3% Y/Y.
Natasha Arya
Research Associate
Biotechnology
North America
Industry View
Attractive
Sequential weekly TRx growth for antipsychotics was +0.8% w/w compared to 2.5% the prior week. Exhibit 1 includes our basket of antipsychotics and
antidepressants, Exhibit 2 shows the launch trajectories for select antipsychotics,
and Exhibit 4 depicts TRx momentum over the last year. Exhibit 9 shows the
launch trajectories for select antidepressants. See inside for additional charts on key
trends.
Total scripts for bipolar depression medications1 grew +0.9% w/w. Rolling 4-week
TRx was +0.7% w/w. On a Y/Y basis, TRx grew +3.5% for the current week, +2.9%
for rolling 4-week, and +3.0% for rolling 12-week.
Acadia: Nuplazid for Parkinson's disease psychosis
• Weekly TRx grew -5% w/w, -2% Y/Y, and rolling 12-wk +7% Y/Y ( Exhibit 6 )
• New prescriptions (NRx) / TRx were 46% for the week
Axsome: Auvelity for major depressive disorder and agitation in Alzheimer's
dementia
• Weekly TRx grew 0% w/w, +34% Y/Y, and rolling 12-wk +33% Y/Y ( Exhibit
10 )
• New prescriptions (NRx) / TRx were 58% for the week
Neurocrine: Ingrezza for tardive dyskinesia and Huntington's disease chorea
• Weekly TRx grew 0% w/w, +21% Y/Y, and rolling 12-wk +21% Y/Y ( Exhibit
12 )
• New prescriptions (NRx) / TRx were 45% for the week
Momentum of top outpatient drugs :
Exhibit 1:
Notable drug total prescriptions (TRx). All figures are rounded to the
nearest hundred because IQVIA does not allow publication of exact Rx counts.
~TRx / Week ending
07/17/26
07/24/26
07/31/26
08/07/26
Antipsychotics
Nuplazid (pimavanserin)
Caplyta (lumateperone)
1,700
…
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer